Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe disease in human with an overall case-fatality rate of >35%. Effective antivirals are crucial for improving the clinical outcome of MERS. Although a number of repurposed drugs, convalescent-phase plasma, antiviral peptides, and neutralizing antibodies exhibit anti-MERS-CoV activity in vitro, most are not readily available or have not been evaluated in nonhuman primates. We assessed 3 repurposed drugs with potent in vitro anti-MERS-CoV activity (mycophenolate mofetil [MMF], lopinavir/ritonavir, and interferon-β1b) in common marmosets with severe disease resembling MERS in humans. The lopinavir/ritonavir-treated and interferon-β1b-treated animals had better outcome than the untreated animals, with improved clinical (mean clinical scores ↓50.9%-95.0% and ↓weight loss than the untreated animals), radiological (minimal pulmonary infiltrates), and pathological (mild bronchointerstitial pneumonia) findings, and lower mean viral loads in necropsied lung (↓0.59-1.06 log10 copies/glyceraldehyde 3-phosphate dehydrogenase [GAPDH]; P < .050) and extrapulmonary (↓0.11-1.29 log10 copies/GAPDH; P < .050 in kidney) tissues. In contrast, all MMF-treated animals developed severe and/or fatal disease with higher mean viral loads (↑0.15-0.54 log10 copies/GAPDH) than the untreated animals. The mortality rate at 36 hours postinoculation was 67% (untreated and MMF-treated) versus 0-33% (lopinavir/ritonavir-treated and interferon-β1b-treated). Lopinavir/ritonavir and interferon-β1b alone or in combination should be evaluated in clinical trials. MMF alone may worsen MERS and should not be used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435 · cited 1×
“acute respiratory disease, which is often complicated by acute respiratory distress syndrome and multiorgan failure [3, 4].”
BackgroundUse of convalescent plasma therapy in SARS patients in Hong Kong
Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., Chan, P., Wong, K. C., Leung, C. B., & Cheng, G. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1271-9 · Cited by 958
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Self-citationde Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Hung, I. F., To, K. K., Lee, C.-K., Lee, K.-L., Chan, K., Yan, W.-W., Liu, R., Watt, C.-L., Chan, W.-M., Lai, K.-Y., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq106 · Cited by 678
Self-citationDyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 660
Interspecies transmission and emergence of novel viruses: lessons from bats and birds
Chan, J. F.-W., To, K. K.-W., Tse, H., Jin, D.-Y., & Yuen, K.-Y. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.005 · Cited by 616
Self-citationOmrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493
Rapid generation of a mouse model for Middle East respiratory syndrome
Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S. S., Fett, C., Zhao, J., Gale, M. J., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452
Chu, H., Zhou, J., Wong, B. H.-Y., Li, C., Chan, J. F.-W., Cheng, Z.-S., Yang, D., Wang, D., Lee, A. C.-Y., Li, C., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv380 · Cited by 448
Self-citationTreatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Zhou, J., Chu, H., Li, C., Wong, B. H.-Y., Cheng, Z.-S., Poon, V. K.-M., Sun, T., Lau, C. C.-Y., Wong, K. K.-Y., Chan, J. Y.-W., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 428
Self-citationKindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03659-14 · Cited by 407
Lau, S. K. P., Lau, C. C. Y., Chan, K.-H., Li, C. P. Y., Chen, H., Jin, D.-Y., Chan, J. F. W., Woo, P. C. Y., & Yuen, K.-Y. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 392
Self-citationStructure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4067 · Cited by 388
Self-citationBroad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Self-citationSoo, Y. O. Y., Cheng, Y., Wong, R., Hui, D. S., Lee, C. K., Tsang, K. K. S., Ng, M. H. L., Chan, P., Cheng, G., & Sung, J. J. Y. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00956.x · Cited by 381
de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
Weingartl, H., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G., Jones, S., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344
Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.003 · Cited by 322
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 253
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, E., Titecat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 248
Chan, J. F.-W., Chan, K.-H., Choi, G. K.-Y., To, K. K.-W., Tse, H., Cai, J.-P., Yeung, M. L., Cheng, V. C.-C., Chen, H., Che, X.-Y., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit123 · Cited by 220
Self-citationJiang, L., Wang, N., Zuo, T., Shi, X., Poon, K.-M. V., Wu, Y., Gao, F., Li, D., Wang, R., Guo, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008140 · Cited by 218
Self-citationHart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A. L., Okumura, A., Peng, X., Thomas, M. J., van Doremalen, N., Haddock, E., Nagy, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004250 · Cited by 210
Agrawal, A. S., Garron, T., Tao, X., Peng, B.-H., Wakamiya, M., Chan, T.-S., Couch, R. B., & Tseng, C.-T. K. (2015) · Journal of Virology · doi:10.1128/jvi.03427-14 · Cited by 208
Shalhoub, S., Farahat, F., Al-Jiffri, A., Simhairi, R., Shamma, O., Siddiqi, N., & Mushtaq, A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv085 · Cited by 189
Chu, H., Zhou, J., Ho-Yin Wong, B., Li, C., Cheng, Z.-S., Lin, X., Kwok-Man Poon, V., Sun, T., Choi-Yi Lau, C., Fuk-Woo Chan, J., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 179
Self-citationGao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02433-13 · Cited by 175
Raj, V. S., Smits, S. L., Provacia, L. B., van den Brand, J. M. A., Wiersma, L., Ouwendijk, W. J. D., Bestebroer, T. M., Spronken, M. I., van Amerongen, G., Rottier, P. J. M., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02935-13 · Cited by 173
Chan, J. F. W., Li, K. S. M., To, K. K. W., Cheng, V. C. C., Chen, H., & Yuen, K.-Y. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.10.002 · Cited by 162
Self-citationChan, K.-H., Chan, J. F.-W., Tse, H., Chen, H., Lau, C. C.-Y., Cai, J.-P., Tsang, A. K.-L., Xiao, X., To, K. K.-W., Lau, S. K.-P., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.03.015 · Cited by 160
Self-citationDu, L., Zhao, G., Yang, Y., Qiu, H., Wang, L., Kou, Z., Tao, X., Yu, H., Sun, S., Tseng, C.-T. K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00433-14 · Cited by 140
Self-citationThe Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
de Wit, E., Prescott, J. B., Baseler, L. J., Bushmaker, T., Thomas, T., Lackemeyer, M. G., Martellaro, C., Milne-Price, S., Haddock, E., Haagmans, B. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069127 · Cited by 139
Spanakis, N., Tsiodras, S., Haagmans, B. L., Raj, V. S., Pontikis, K., Koutsoukou, A., Koulouris, N. G., Osterhaus, A. D. M. E., Koopmans, M., & Tsakris, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.026 · Cited by 130
Coleman, C. M., Matthews, K. L., Goicochea, L., & Frieman, M. B. (2013) · Journal of General Virology · doi:10.1099/vir.0.060640-0 · Cited by 126
An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus
Yao, Y., Bao, L., Deng, W., Xu, L., Li, F., Lv, Q., Yü, P., Chen, T., Xu, Y., Zhu, H., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit590 · Cited by 125
Self-citationMERS CoV Infection in Two Renal Transplant Recipients: Case Report
AlGhamdi, M., Mushtaq, F., Awn, N., & Shalhoub, S. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13085 · Cited by 103
Chan, J. F., Choi, G. K.-Y., Tsang, A. K. L., Tee, K., Lam, H., Yip, C. C., To, K. K., Cheng, V. C., Yeung, M. L., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01224-15 · Cited by 93
Self-citationKhalid, M., Rabiah, F. A., Khan, B., Mobeireek, A. F., Butt, T. S., & Mutairy, E. A. (2014) · Antiviral Therapy · doi:10.3851/imp2792 · Cited by 92
HIV Protease Inhibitors Impact on Apoptosis
Rizza, S. A., & Badley, A. D. (2008) · Medicinal Chemistry · doi:10.2174/157340608783331443 · Cited by 39
Cited by
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Self-citationSARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
“However, lopinavir and ritonavir improve the outcome in common marmosets when treatment is initiated 6 hours after infection with MERS-CoV 105 .”
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Self-citationF. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06022-5 · Cited by 2,105
“In an animal model of MERS-CoV infection, treatment with lopinavir/ritonavir or IFN-β1b was associated with virologic, histologic and clinical improvement versus placebo [191].”
Metadata
- Authors
- Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., Cai, J.-P., Chu, H., Zhou, J., Chen, H., Qin, C., & Yuen, K.-Y.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-07-21
- Volume
- 212
- Issue
- 12
- Pages
- 1904-1913
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1945961678
- Cited by
- 608
- References
- 45
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.